Cargando…

The N(6)-Methyladenosine-Modified Pseudogene HSPA7 Correlates With the Tumor Microenvironment and Predicts the Response to Immune Checkpoint Therapy in Glioblastoma

BACKGROUND: Glioblastoma (GBM), one of the most aggressive tumors of the brain, has no effective or sufficient therapies. Identifying robust biomarkers for the response to immune checkpoint blockade (ICB) therapy, a promising treatment option for GBM patients, is urgently needed. METHODS: We compreh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Rongrong, Li, Boyan, Zhang, Shouji, He, Zheng, Pan, Ziwen, Guo, Qindong, Qiu, Wei, Qi, Yanhua, Zhao, Shulin, Wang, Shaobo, Chen, Zihang, Zhang, Ping, Guo, Xing, Xue, Hao, Li, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329659/ https://www.ncbi.nlm.nih.gov/pubmed/34354698 http://dx.doi.org/10.3389/fimmu.2021.653711

Ejemplares similares

The N(6)-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2
por: Li, Boyan, et al.
Publicado: (2022)

Comprehensive Analysis of the Tumor Immune Microenvironment Landscape in Glioblastoma Reveals Tumor Heterogeneity and Implications for Prognosis and Immunotherapy
por: Zhao, Rongrong, et al.
Publicado: (2022)

Synchronous Disintegration of Ferroptosis Defense Axis via Engineered Exosome‐Conjugated Magnetic Nanoparticles for Glioblastoma Therapy
por: Li, Boyan, et al.
Publicado: (2022)

miR‐3184‐3p enriched in cerebrospinal fluid exosomes contributes to progression of glioma and promotes M2‐like macrophage polarization
por: Xu, Hao, et al.
Publicado: (2022)

Hypoxic glioma-derived exosomes promote M2-like macrophage polarization by enhancing autophagy induction
por: Xu, Jianye, et al.
Publicado: (2021)

SPI1-induced downregulation of FTO promotes GBM progression by regulating pri-miR-10a processing in an m6A-dependent manner
por: Zhang, Shouji, et al.
Publicado: (2022)

The dual role of glioma exosomal microRNAs: glioma eliminates tumor suppressor miR-1298-5p via exosomes to promote immunosuppressive effects of MDSCs
por: Qi, Yanhua, et al.
Publicado: (2022)

Glioblastoma upregulates SUMOylation of hnRNP A2/B1 to eliminate the tumor suppressor miR-204-3p, accelerating angiogenesis under hypoxia
por: Guo, Qindong, et al.
Publicado: (2023)

The Non-N(6)-Methyladenosine Epitranscriptome Patterns and Characteristics of Tumor Microenvironment Infiltration and Mesenchymal Transition in Glioblastoma
por: Xu, Jianye, et al.
Publicado: (2022)

EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3
por: Pan, Ziwen, et al.
Publicado: (2022)

Mesenchymal stem cells, as glioma exosomal immunosuppressive signal multipliers, enhance MDSCs immunosuppressive activity through the miR-21/SP1/DNMT1 positive feedback loop
por: Qiu, Wei, et al.
Publicado: (2023)

SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages
por: Fan, Yang, et al.
Publicado: (2023)

HSPA6 is Correlated With the Malignant Progression and Immune Microenvironment of Gliomas
por: Zhou, Xiang, et al.
Publicado: (2022)

Cell surface GRP78 regulates BACE2 via lysosome-dependent manner to maintain mesenchymal phenotype of glioma stem cells
por: Chen, Zihang, et al.
Publicado: (2021)

Positive natural selection of N6-methyladenosine on the RNAs of processed pseudogenes
por: Tan, Liqiang, et al.
Publicado: (2021)

Pancancer landscape analysis of the thymosin family identified TMSB10 as a potential prognostic biomarker and immunotherapy target in glioma
por: Xiong, Ye, et al.
Publicado: (2022)

PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition
por: Gao, Zijie, et al.
Publicado: (2022)

TGFβ1‐induced beta‐site APP‐cleaving enzyme 2 upregulation promotes tumorigenesis through the NF‐κB signalling pathway in human gliomas
por: Wang, Huizhi, et al.
Publicado: (2020)

MicroRNA-29a-3p delivery via exosomes derived from engineered human mesenchymal stem cells exerts tumour suppressive effects by inhibiting migration and vasculogenic mimicry in glioma
por: Zhang, Zongpu, et al.
Publicado: (2021)

Pseudogene HSPA7 is a poor prognostic biomarker in Kidney Renal Clear Cell Carcinoma (KIRC) and correlated with immune infiltrates
por: Ding, Chunjin, et al.
Publicado: (2021)

N6-Methyladenosine Regulator-Mediated Immue Patterns and Tumor Microenvironment Infiltration Characterization in Glioblastoma
por: Xiong, Wu, et al.
Publicado: (2022)

Identification and validation of SNHG gene signature to predict malignant behaviors and therapeutic responses in glioblastoma
por: Fan, Yang, et al.
Publicado: (2022)

Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma
por: Liu, Yong, et al.
Publicado: (2022)

Upregulation of HSPA1A/HSPA1B/HSPA7 and Downregulation of HSPA9 Were Related to Poor Survival in Colon Cancer
por: Guan, Yufeng, et al.
Publicado: (2021)

HSPA1A, HSPA2, and HSPA8 Are Potential Molecular Biomarkers for Prognosis among HSP70 Family in Alzheimer's Disease
por: Dong, Yeqing, et al.
Publicado: (2022)

Links Between N (6)-Methyladenosine and Tumor Microenvironments in Colorectal Cancer
por: Zhang, Yundi, et al.
Publicado: (2022)

Tumor-derived exosomes deliver the tumor suppressor miR-3591-3p to induce M2 macrophage polarization and promote glioma progression
por: Li, Ming, et al.
Publicado: (2022)

Differential expression of checkpoint markers in the normoxic and hypoxic microenvironment of glioblastomas
por: Petterson, Stine Asferg, et al.
Publicado: (2022)

N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy
por: Guo, Liting, et al.
Publicado: (2021)

A Novel Pseudogene Methylation Signature to Predict Temozolomide Outcome in Non-G-CIMP Glioblastomas
por: Li, Bowen, et al.
Publicado: (2022)

Pseudogene MAPK6P4-encoded functional peptide promotes glioblastoma vasculogenic mimicry development
por: Zhang, Mengyang, et al.
Publicado: (2023)

Pseudogenes
por: Tutar, Yusuf
Publicado: (2012)

N6-methyladenosine-associated prognostic pseudogenes contribute to predicting immunotherapy benefits and therapeutic agents in head and neck squamous cell carcinoma
por: Tan, Liqiang, et al.
Publicado: (2022)

Upregulation of Heat Shock Proteins (HSPA12A, HSP90B1, HSPA4, HSPA5 and HSPA6) in Tumour Tissues Is Associated with Poor Outcomes from HBV-Related Early-Stage Hepatocellular Carcinoma
por: Yang, Zongguo, et al.
Publicado: (2015)

Functional redundancy of HSPA1, HSPA2 and other HSPA proteins in non-small cell lung carcinoma (NSCLC); an implication for NSCLC treatment
por: Sojka, Damian Robert, et al.
Publicado: (2019)

Biomarkers Associated with Immune Checkpoint, N6-Methyladenosine, and Ferroptosis in Patients with Restenosis
por: Tong, Xiao, et al.
Publicado: (2023)

Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy
por: Zhou, Xianyong, et al.
Publicado: (2023)

Identification and characterization of N6‐methyladenosine modification of circRNAs in glioblastoma
por: Zhang, Yuhao, et al.
Publicado: (2021)

CircRNA-derived pseudogenes
por: Dong, Rui, et al.
Publicado: (2016)

Pseudogene.org: a comprehensive database and comparison platform for pseudogene annotation
por: Karro, John E., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_19g6jq07ttmaabuck58lcoa3o9